Download PDF

Steven Macwan

Born in Israel and residing in Haifa, 43 years old, and a proud father of three children.

  • Executive with 11 years of experience as CEO ,Chief Revenue Officer & VP Sales , Business Development 
  • Directly responsible for secured funding rounds totaling $62 million.
  • Attended Harvard Business School - Executive Education Program , Technion ( BSc, MBA)
  • Expertise : Sensor Technology , Robotics, Image processing , Mobile APP AI machine learning ,deep learning , medical and surgical procedures

Education

2017

Executive Education Program, Boston

Harvard Business School

20092011

Master’s Degree in BusinessAdministration (MBA)

Technion - Israel Institute of Technology

20012005

Bachelor’s Degree in Molecular Biochemistry (B.Sc)

Technion - Israel Institute of Technology

20232024

AI Engineering , Computer Vision

IBM Certification

Work experience

20232024

CEO

MICROSTEER - Robotic steering system for precision tumor removal surgeries

Funding - Secured NIS 2.5 Million from the Israel Innovation Authority & NGT Fund 

  • Link - Steven Joins Microsteer Robotics as New 
  • R&D - Manage multidisciplinary team of 7 engineers,
  • Expertise : Robotics, Computer vision , AI & Machine Learning , Sensor Technology , Simulation ,  Real time SW development, motion planning ,and laser based prototyping 
20132023

Chief Revenue Officer

CNOGA MEDICAL LTD

  • 2017 - 2020   VP Global sales 
  • 2015 - 2017   VP Business Development & Shanghai Office
  • 2013 - 2015   Business Development & Europe , Asia Sales Director
20062013

Team Leader - Analytical chemistry

Taro Pharmaceuticals

19982001

Combat Engineering Corp

Israeli Defense Forces (IDF)

  • Staff Sergeant , Reserve - Bomb Disposal Unit.
  • Commanding course , Shooting instructor course

Funding & Investments

2014

Directly responsible for raising $12M

Cnoga Medical

Link - Globes News CNOGA MEDICAL Raised $12Mil

Identified and engaged potential investors - Hong Kong Private Equity Go Capital & Ehud Olmert Consulting

  • Preparing a global business plan, market analysis, financial modeling, sales forecasting, budget projections and sales strategy.
  • Created investor pitch decks, identified and engaged potential investors
  • Oversaw due diligence, negotiated term sheets and company valuation
2017

Directly responsible for raising $50M

Cnoga Medical

Link - Globes News CNOGA MEDICAL Raised $50Mil

Identified and engaged potential investors - BOE 

  • Negotiated term sheets , company valuation and commercial agreement (Co Development )
  • Preparing China focused business plan, market analysis, financial modeling,
  • Global sales forecasting, budget projections and sales strategy.
2024

Directly responsible for securing NIS 2.5M

MicroSteer Robotics

20192023

Buyout & Pre IPO

Cnoga Medical

2019 Pre IPO Initial discussion with investment banks, such as JP Morgan and UBS

2022- 2023  Buyout deal with Reliance Group reach to level of SPA . Deal Failed reject by single board member 

Business Development - Co Developemnt

Apple , Samsung , Maxim Integrated , Reliance Group Device , Microsoft, Amazon, Qualcomm Ventures , J&J , Edwards Lifesciences , Fresenius , Oppo , Huawei, Humai , Dai-ichi Japan ,Polar

R&D MANAGEMENT

Serving as the CEO of Microsteer, we developed endoscopic add-on robotic steering systems for the removal of early-stage cancerous tumors.Managed a multidisciplinary team of 7 engineers, gaining expertise in robotics, electronics, real-time software development, motion planning, simulation, sensor integration, and machine learning.

Challenge

The entire R&D team was drafted into the military in November 2023, I was forced to take over the entire project on my own, which required me to quickly gain in-depth expertise in every component of the system.

before conducting safe surgery faced 33 different single points of failures that need to overcome  , ranging from  electromagnetic interference, micro motors mechanic , thermodynamic issues ,  control , software , and wiring . Despite these challenges, I successfully recruited three highly skilled temporary engineers. Together, we worked relentlessly, day and night, to troubleshoot and resolve these complex technical problems under extreme time pressure.

I personally oversaw and conducted all system tests, including 12 tissue surgeries and 4 animal surgeries, which were essential  identifying critical design improvements,

Achievement

we presented the final prototype to a team of 4 top Israeli surgeons. They conducted the surgery using our robotic system, and the procedure was a complete success the first-ever successful use of our robotic system within a live body, which allow us to secure funding of NIS 2.5 Million .

Business Development

Product

Expanding on Cnoga’s core medical technology, we’ve developed modules and system-on-chips (SoCs) for the fitness sector that combine advanced image processing with thermal and bioimpedance signals. Using AI, machine learning, and cloud computing, these solutions can be easily integrated into various form factors like mobile phones, smartwatches, and other wearables

Challenge

Co-developing system-on-chip (SoC) solutions for monitoring physiological parameters in health and sports applications requires transitioning from DSP-based machine learning to a hybrid model, where data is locally pre-processed and further analyzed using deep learning on the cloud in real-time. This shift to a new processor optimized for wearable devices necessitates strategic partnerships with industry-leading companies

Achievements:

Engaged with Apple, Samsung, Qualcomm Ventures, Garmin, and Polar, resulting in Samsung providing a custom phone with camera access for Cnoga technology integration. Explored SoC development with Maxim Integrated, which proposed a co-development project later introduced to Analog Devices for further exploration

Sales Management

Below - TV News Article 

  • Israel TV News Article about Cnoga Medical 
  • Workshop attended by distributors from 15 countries arrived to Cnoga Offices 
  • Italy TV News Use case of Cnoga Products in Italy - Telemedicine & Covid monitoring 
  • Interview Prof. Andreas Pfützner

Achievements & Territories

  • Increased sales from zero to $5 million in three years
  •  Europe, China, Brazil India, Australia & NZ, United States, and Japan.

Business Models

  • Work closely with 25 strategic distribution partners across worldwide
  • B2B - Distributors , Telemedicine companies , Clinics , Pharmacies 
  • B2C - Direct sales to customers of our non invasive glucose meter 
  • B2G - Securing contracts worth $45milin government project monitoring over 3 years

Mobile & Web Application

Led the commercialization of an Azure-based AI platform with API and SDK integration, enabling deep learning for non-invasive health monitoring.

Products

  • Cnoga Device - Non Invasive sensor 
  • Mobile & Web APP 
  • API & SDK Integration

Business Model

  • SaaS model with an initial fixed fee
  • API fee or pay-per-measurement model for remote/mobile health services
  • SDK license fee + initial hardware fixed fee

Achievement

  • Implemented a cloud-based SaaS model for Cnoga’s services, targeting  B2C ,B2B and B2G use cases.
  • Integrated devices and cloud solutions for customers, offering flexibility to connect through APIs or directly to hardware via SDK.
  • Enabled telemedicine services for clinics, hospitals, and government projects to remotely monitor patients, especially during COVID-19 and for chronic conditions.

Armed Forces

  • NATO’s Explosive Ordnance Disposal Center of Excellence (EOD-COE) collaborated with Cnoga to assess blood parameters and hemodynamic measurements during the deployment of new exoskeleton technologies for military forces
  • The Brazilian Army’s Periodic Health Assessment (PHA) serves as a screening tool to evaluate the individual medical readiness of service members.
  • The Brazilian Army also utilizes our system to register and conduct health screenings for immigrants at the Brazil-Venezuela border.

China Market

Overview

  • Established and managed Cnoga’s wholly-owned subsidiary in Shanghai,
  • leading a team of 25 employees across sales, marketing, technical support, and software development.
  • Set up a fully-owned assembly site in the Changzhou Medical Park to support production and operations.
  • Managed national distributors and 30 sub-distributors at the provincial level to ensure effective product distribution and market penetration.

Product & Business Model

  • Diagnostic device combined with a cloud-based patient management platform.
  • Primarily B2B and B2G, collaborating with dedicated companies to deploy remote monitoring system projects funded by the Chinese government.
  • API fee or SDK Licence fee + HW Cost 

Projects 

Brazil Market

Sales Channels

  • State level municipalities ministry of health utility the benefits web Application and non inasicve sensor for gaining insight of entire population  either in local community clinics and Pharmacies Health Point.
  • same masss population screening was replicated in India in collaboration with Jio-Reliance Group during Covid vaccination and in China  , such projects not only generate revenue but also enable use to expand our training set to variues ethnographic population world wide

Product Diagnostic device + Cnoga Cloud Patient management platform 

Business Model : Rental fee of HW + Monthly fee payment per measurement

References  

Amazon River - Rural Communities

Cnoga Medical collaborated with the Presbyterian Church of Manaus and Universidad Presbyterian Mackenzie to assess non-invasive bio-parameters in the riverine communities of the Rio Negro in the Amazon.

The MTX device helped diagnose anemia in a significant portion of the population, enabling immediate treatment. It also detected bradycardia in two patients, leading to referrals for pacemaker evaluation, and identified cases of hypertension, allowing for control strategies to be implemented. 

Link - Cnoga Medical Projects 

Marketing & Communication

Contact me

Message sent successfully.